Prevalence of Blood Pathogens among Transfused Patients in Ekpoma, Nigeria by Momoh, ARM et al.
International Journal of Community Research http://www.arpjournals.com
ISSN: 2315 – 6562
Momoh et al., IJCR 2013; 2(4): 72-76. 72
PREVALENCE OF BLOOD PATHOGENS AMONG TRANSFUSED PATIENTS IN 
EKPOMA, NIGERIA
1MOMOH A.R.M., 2OKOGBO F.O., 3ORHUE P.O., 4AISABOKHALE F.A., 
1OKOLO P.O.
Department of 1Medical Microbiology, 2Obstetrics and Gynaecology, 4Haematology, Faculty of Clinical Sciences; 
3Microbiology, Faculty of Natural Sciences; Ambrose Alli University, Ekpoma-Nigeria.
Correspondence: mcsionelphilrazzy@yahoo.com
ABSTRACT
With the advent of 21st century technology that has resulted in the development of sophisticated equipments, blood 
supply is thought to be safer than ever. This study therefore, investigates the incidence and prevalence of transfusion 
transmitted infections in patients. The study was carried out on 55 hospitalized cohorts who for some medical or 
surgical reasons needed blood transfusion. Using standard laboratory procedures, the post-transfused blood samples
were screened for parasite, bacterial species and viral antibodies. Results showed that 58.18% (32 samples) were 
positive for transfusion-transmissible infections. Co-infections of several bacterial species, viral antibodies and 
parasites were also observed in the transfused blood. Specifically, 15 samples were positive for viral antibodies 
[Hepatitis C (10.90%) and hepatitis B (16.36%)], 25 samples for parasites [Plasmodium falciparum (40.00%), and 
Plasmodium malariae (5.45%)] and 19 samples for bacterial spp [Staphylococcus aureus (10.90%), Escherichia coli
(7.27%), Klebsiella spp (7.27%) and Staphylococcus epidermidis (9.09%)]. Our results suggest therefore, that 
transfusion-transmissible infections from donors to recipients might exist and this calls for attention. Hence, 
screening donor blood for HIV and hepatitis viruses alone is not sufficient to justify that donor blood is safe. As 
such, there is a need to further screen transfusion blood for possible transfusion-transmissible infections.
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INTRODUCTION
A transfusion transmitted infection (TTI) is a virus, 
parasite, or other potential pathogen that can be 
transmitted in donated blood through transfusion to a 
recipient. The most common examples are HIV, 
hepatitis B, hepatitis C and several other viral 
infections that can cause hemorrhagic fevers (Weiss
et al., 2005). Nevertheless, diseases exist that are not 
usually transmitted through blood contact, but by 
insect or other vectors and are termed ‘vector-borne’; 
even though the causative agents can be found in 
blood. Examples of such vector-borne diseases 
include West Nile fever and malaria.
Although blood-borne diseases can be transmitted by 
other means like high risk sexual behavior and 
intravenous drug use, those via blood transfusion 
queries patients’ trust on health care providers. Until 
date, blood transfusion departments remain the major 
portal to screen, monitor and control infection 
transmission through blood transfusion (Zeesham et 
al., 2007). 
In developing countries like Nigeria, blood safety is 
an issue of concern and despite the emergence of the 
21st century technology which has resulted in the 
development of more sophisticated facilities and 
procedures, the prevalence of blood-transfusion 
infections still persist. This is evident in the report on 
bacterial contamination of blood products by Kitchen 
and Davis (2005).
In Europe and the United States however, continuous 
improvement on more sensitive serologic methods 
and nucleic acid amplification test (NAT), have 
resulted in  phenomenal decrease in the residual risk 
of viral transmission recorded in 2000 to less than 
1:250,000 for hepatitis C virus (HCV) and 1: 1.3M 
for HIV (Velati et al., 2007; Allain, 2002). In fact, 
over the past three decades, the risk of transfusion 
transmitted infections has been dramatically reduced 
through the introduction of routine donor laboratory 
screening of blood-borne pathogens (Luban, 2005; 
Allain, 2002). It has even been estimated that the 
mortality risk of severe post-transfusion sepsis ranges 
from 1:230,000 to 1:625,000 donor exposures 
(Blajchman, 2002; Ness et al., 2001; Perez et al., 
2001). 
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This cannot be said of Africa and particularly 
Nigeria, where factors preventing safe blood supply 
are common place. The issue is further complicated 
considering the fact that existing blood banks are few 
and 60% of health facilities lack blood banks in 
Nigeria. These inadequacies compel physicians and 
other health care givers to rely on transfusing patients 
in dire need of blood with freshly donated blood that 
are subjected to routine screening. By contrast, 
transfusion transmitted infections still pose a great 
threat to blood Safety in Nigeria.
Considering the above literatures therefore, this study 
investigates the incidence and prevalence of 
transfusion transmitted infections in transfused blood 
from donors
MATERIALS AND METHODS
Study area: The study was carried out in Ekpoma, 
Edo State, situated in the tropical belt of South-South 
Nigeria. Ekpoma lies between latitude 60 40o N 60 
45o N and longitude 60 05o E 60 10 o E (Obabori et 
al., 2006). It is also the administrative headquarters of 
Esan West Local Government Area of Edo State, 
Nigeria. Since it’s inception as the Local Government 
headquarters and host to the State owned Ambrose 
Alli University, the town has grown into an urban 
center with a significant rise in population.
Study population: The study participants were 55 
hospitalized cohorts who for some medical or 
surgical reasons needed blood transfusion and blood 
samples were collected at the health centres from 
both patients (recipients) and donors, pre and post 
transfusion.
Ethical consideration: The study was conducted in 
compliance with the Declaration on the Right of the 
Patient (WMA, 2000). Also, informed consent was 
obtained from all subjects enrolled for the study.
Hematological Screening: Inclusion criteria for the 
cohorts entailed a negative pre-transfusion screen (nil 
blood pathogen), using standard but commercially 
sourced kits.
Microbiology and Serology: All pre-transfusion 
blood screened for the cohorts returned negative to 
culture and serologic results using standard 
microbiological methods as well as serologic 
screening kits.
Isolation and Identification: All post-transfused 
blood samples were inoculated onto Nutrient agar, 
MacConkey agar and Blood agar plates by streaking. 
Inoculated plates were incubated aerobically at 370C 
for 24hrs and discrete colonies therein, were picked 
from the growth and Gram stained while further sub-
culturing was done to obtain pure cultures for 
biochemical tests.
Serological test were conducted on the samples for 
HIV I & II, Hepatitis A, B, C as well as Syphilis. 
Staining of thin film on dried slides was also 
conducted for all the post-transfusion samples 
(Arness et al., 2003; Momoh et al., 2012)
Data analysis: Descriptive analysis was performed 
on the laboratory test results using SPSS version 17 
and presented in tables.
RESULTS
Table 1 represents micro-organisms and microbial 
antibodies detected from post transfusion blood 
samples. The results showed 32 (58.18%) samples to 
be positive for transfusion-transmissible infections.
Also, co-infections of bacterial species, viral 
antibodies and parasites were also observed in the 
post transfusion blood samples.
After staining, 25 of the post transfusion blood 
samples were positive for Plasmodium falciparum
(22; 40.00%), and Plasmodium malariae (3; 5.45%) 
parasites. For bacterial infection, four bacterial 
species were isolated 72 hrs post-transfusion from 19 
hitherto sterile blood samples and are distributed as 
follows; Staphylococcus aureus (6; 10.90%), 
Escherichia coli (4; 7.27%), Klebsiella spp (4; 
7.27%) and Staphylococcus epidermidis (5; 9.09%).
For viral infection, 15 samples were positive for viral 
antibodies after serologic screening some 36-45 days 
post-transfusion and they include Hepatitis C (6; 
10.90%), and hepatitis B (9; 16.36%).
DISCUSSION
Blood transfusion no doubt, has saved millions of 
live worldwide. However, it is reported that 
recipients stand the risk of becoming infected with 
blood-borne diseases through transfusion of infected 
blood and blood products (UNAIDS, 2007). The 
observation that there were blood borne infections 
(58.18%) in the studied post transfusion blood 
samples, is in line with the study by Weiss et al. 
(2005) who reported such infections in 53% (373 of 
709) patients. This has led to patients’ blood being 
tested for abnormal liver function, neutropenia, and 
possible history of IV drug use in order to rule out 
transfusion infection.
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Table 1. Prevalence of micro-organisms and microbial antibodies detected from post transfusion blood
Isolated transfusion transmitted pathogens Specificity Number Percentage
Bacterial species




























The detection of bacterial spp in the post transfusion 
blood samples is in line with the reports by Fasola 
and Otegbayo (2002) that 12.5% of patients who 
received blood transfusion were at risk of post-
transfusion hepatitis. According to Picker (2012), 
Walther-Wenke et al. (2006), and Kitchen and Davis 
(2005), bacterial contamination, especially of platelet 
concentration, stored at room temperature that allows 
for bacterial proliferation, has been recognized as the 
most common cause of transfusion-transmitted 
infections.
Similarly, the 45.45% parasites discovery in the post 
transfused blood sample signifies that malaria is 
prevalent in Nigeria. In fact, a high malaria parasite 
prevalence rate of 40% has also been reported in 
transfused donor blood with Plasmodium falciparum
being the most prevalent (Ibhanesebhor et al., 1996).
Indeed, malaria is endemic in Nigeria (Erhabor et al., 
2007; Ibhanesebhor et al., 1998) and sometimes
asymptomatic. While about 1500 cases of malaria are 
diagnosed in the United States each year, over 1,500 
cases of malaria are diagnosed daily in Nigeria
(Ibhanesbhor et al., 1996; Nwaneka et al., 2004; 
Falade et al., 2009); hence, its detection in the post 
transfused blood samples is unexpected.
The 27.27% detection of viral infections (hepatitis B 
and C) in post transfused blood sample indicated that 
hepatitis B and C viruses may be circulating in 
recipients’ blood. Similar assertions have been made 
in Ibadan and residents of other cities in Nigeria 
(Afolabi et al., 2013). In accordance with the findings 
of this study, several studies in Nigeria have also 
detected hepatitis C antibodies among blood donor 
(Isa et al., 2009; Ayolabi et al., 2006; Chukwurah et 
al., 2005; Egah et al., 2004; Fashola, et al.2001). The 
10.91% prevalence of hepatitis C antibodies in post 
transfusion blood in this study is high compared to 
the 1.8% reported in Kaduna- Nigeria (Isa et al., 
2009), 4.96% in Ibadan-Nigeria (Fashola et al., 
2001), 6.0% in Jos-Nigeria (Egah et al., 2004), 7.6% 
in South-Eastern Nigeria (Chukwurah, et al., 2005) 
and 8.4% in Lagos, Nigeria (Ayolabi et al., 2006).
The presence of these pathogenic organisms, 
particularly Staphylococcus aureus and 
Staphylococus epidermidis may be attributed to point 
of puncture of the needle, either in the donor or the 
recipient, as these organisms constitute the normal 
skins microbial flora. However, same cannot be said 
of hepatitis viruses or the plasmodium species.
Any blood borne pathogen has the potential to be 
transmitted by blood transfusion. Due to occasional 
report of blood borne diseases such as Babesiosis, 
Chagas disease, Leishmaniasis and malaria in the 
United States, it is pertinent to note that since 2007, 
the blood supply in the US has been screened for 
Chagas disease (aetiologic agent-Trypanosoma 
cruzi), making the risk of transfusion-transmitted 
Trypanosome cruzi rare (Ochie et al., 2012). 
Transfusion-transmitted infections (TTIs), though 
common, are largely unaccepted in Nigeria. Due to 
the difficulty in ascertaining the inherent pathogens 
of any given donor blood which might be lethal, it is 
important to consider as a rule, that all blood and 
body fluids are potentially infectious. Also, the 
possibilities of transfusion-transmitted infections 
might be implicated in the risk of false -positive or -
negative results (Schrezenmeier et al., 2007).
Although the use of standard donor screening 
methods to a large extent, help to reduce the risk of 
an infectious organism being transmitted by blood 
transfusion, it is however, not routine in most health 
facilities in Nigeria prior to transfusion. This has to a 
large extent contributed to the past transfusion 
infection diagnosed in some of the patient. 
Considering the finding of this study, screening 
donor blood for HIV and other viruses and syphilis 
alone is not sufficient to justify donated blood as 
safe. Therefore, there is a need to further screen 
blood for other possible transfusion-transmissible 
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infections. According to Robert et al. (1997), blood 
safety goes beyond screening for pathogens as 
improved methods of collection, handling and storage 
of blood products has to a large extent, decreased 
bacterial contamination in recent years.
Conclusively, the need to screen all donor blood for 
pathogenic organisms cannot be over emphasized. As 
the saying goes, if you cannot make it better, then do 
not make it worse by your actions or inactions. More 
blood banks should be established across Nigeria as 
well as making provisions for the microbiological 
analysis of the donor blood. Efforts should be made 
to ensure that the normal skin flora do not 
contaminate the blood meant for transfusion.
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